Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Clinical Rheumatology
|
November 14, 2016
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)
Ruediger B Mueller, Nazim Reshiti, Toni Kaegi, et al.
Annals of the Rheumatic Diseases
|
September 12, 2015
Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial
Jeremy Sokolove, Michael Schiff, Roy Fleischmann, et al.
Arthritis and Rheumatism
|
March 29, 2002
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial
Stanley Cohen, Eric Hurd, John Cush, et al.
Annals of the Rheumatic Diseases
|
March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial
Vibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Arthritis Care & Research
|
June 20, 2014
Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States
Jeffrey R Curtis, Jie Zhang, Fenglong Xie, et al.
Anticancer Research
|
February 16, 2006
Aberrant crypt foci
Sadir J Alrawi, Michael Schiff, Robert E Carroll, et al.
RMD Open
|
November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study
Michael Schiff, Bernard Combe, Thomas Dörner, et al.
Arthritis Care & Research
|
June 25, 2019
Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate
Roy Fleischmann, Tsutomu Takeuchi, Michael Schiff, et al.
The Journal of Rheumatology
|
April 1, 2005
Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy
Philip J Mease, Ellen M Ginzler, Oscar S Gluck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2009
Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease
Prakash Varadarajan, Lauren M Dunford, Julie A Thomas, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Clinical Rheumatology
|
November 14, 2016
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)
Ruediger B Mueller, Nazim Reshiti, Toni Kaegi, et al.
Annals of the Rheumatic Diseases
|
September 12, 2015
Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial
Jeremy Sokolove, Michael Schiff, Roy Fleischmann, et al.
Arthritis and Rheumatism
|
March 29, 2002
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial
Stanley Cohen, Eric Hurd, John Cush, et al.
Annals of the Rheumatic Diseases
|
March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial
Vibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Arthritis Care & Research
|
June 20, 2014
Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States
Jeffrey R Curtis, Jie Zhang, Fenglong Xie, et al.
Anticancer Research
|
February 16, 2006
Aberrant crypt foci
Sadir J Alrawi, Michael Schiff, Robert E Carroll, et al.
RMD Open
|
November 5, 2015
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study
Michael Schiff, Bernard Combe, Thomas Dörner, et al.
Arthritis Care & Research
|
June 25, 2019
Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate
Roy Fleischmann, Tsutomu Takeuchi, Michael Schiff, et al.
The Journal of Rheumatology
|
April 1, 2005
Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy
Philip J Mease, Ellen M Ginzler, Oscar S Gluck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2009
Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease
Prakash Varadarajan, Lauren M Dunford, Julie A Thomas, et al.
Page
of 9